Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

被引：0

作者：

Mease, Philip ^{[1
,2
]}

Tillett, William ^{[3
,4
]}

de Wit, Maarten ^{[5
]}

Gossec, Laure ^{[6
]}

Husni, M. Elaine ^{[7
]}

Proft, Fabian ^{[9
,10
]}

Ink, Barbara ^{[8
,11
]}

Bajracharya, Rajan ^{[11
]}

Coarse, Jason ^{[12
]}

Lambert, Jeremy ^{[13
]}

Coates, Laura ^{[14
]}

Gottlieb, Alice ^{[15
]}

机构：

[1] Providence St Joseph Hlth, Swedish Med Ctr, Seattle, WA USA

[2] Univ Washington, Sch Med, Seattle, WA USA

[3] Royal Natl Hosp Rheumat Dis, Bath, England

[4] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, England

[5] Stichting Tools, Patient Res Partner, Amsterdam, Netherlands

[6] Sorbonne Univ, Paris, France

[7] Cleveland Clin, Cleveland, OH USA

[8] Charite Univ Med Berlin, Berlin, Germany

[9] Free Univ Berlin, Berlin, Germany

[10] Humboldt Univ, Berlin, Germany

[11] UCB Pharma, Slough, England

[12] UCB Pharma, Morrisville, NC USA

[13] UCB Pharma, Colombes, France

[14] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England

[15] Icahn Sch Med Mt Sinai, Dept Dermatol, Seattle, WA USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2368

引用

页码：4789 / 4792

页数：4

共 50 条

[31] Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
McInnes, Iain B.
Mease, Philip J.
Tanaka, Yoshiya
Gossec, Laure
Husni, M. Elaine
Kristensen, Lars Erik
Warren, Richard B.
Ink, Barbara
Bajracharya, Rajan
Coarse, Jason
Gottlieb, Alice B.
ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 720 - 731
[32] LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
Baraliakos, X.
Deodhar, A.
van der Heijde, D.
van den Bosch, F.
Magrey, M.
Maksymowych, W. P.
Tomita, T.
Xu, H.
Massow, U.
Fleurinck, C.
Vaux, T.
Prajapati, C.
Shepherd-Smith, J.
Marten, A.
Gensler, L. S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 93 - 94
[33] Bimekizumab Treatment Impact on Pain and Fatigue in Patients with Active Psoriatic Arthritis Who Were Biologic DMARD- Naive or Had Inadequate Response or Intolerance to TNF-α Inhibitors: 1-Year Results from Two Phase 3 Studies
Husni, M. Elaine
Mease, Philip J.
Merola, Joseph
Behrens, Frank
Favalli, Ennio G.
McGonagle, Dennis
Tillett, William R.
Tsuji, Shigeyoshi
Ink, Barbara
Bajracharya, Rajan
Lambert, Jeremy
Coarse, Jason
Gossec, Laure
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1035 - 1038
[34] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
Baraliakos, Xenofon
Deodhar, Atul
van der Heijde, Desiree
van den Bosch, Filip
Magrey, Marina
Maksymowych, Walter P.
Tomita, Tetsuya
Xu, Huji
Massow, Ute
Vaux, Tom
Prajapati, Chetan
Manente, Myriam
Marten, Alexander
Gensler, Lianne S.
RHEUMATOLOGY, 2025,
[35] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Ankylosing Spondylitis: 2-Year Results from a Phase 3 Study
Pavelka, Karel
Kivitz, Alan J.
Dokoupilova, Eva
Blanco, Ricardo
Maradiaga, Marco
Tahir, Hasan
Slade, Alan
Wang, Yi
Rohrer, Susanne
Porter, Brian
ARTHRITIS & RHEUMATOLOGY, 2017, 69
[36] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A PHASE 3 STUDY
Pavelka, K.
Kivitz, A. J.
Blanco, R.
Maradiaga, M.
Tahir, H.
Slade, A.
Wang, Y.
Rohrer, S.
Porter, B.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2018, 24 : S107 - S108
[37] Secukinumab Provides Sustained Improvements in Psoriatic Arthritis: 2-Year Efficacy and Safety Results from a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Mease, Philip J.
McInnes, Iain B.
Kirkham, Bruce
Kavanaugh, Arthur
Rahman, Proton
van der Heijde, Desiree
Landewe, Robert B. M.
Nash, P.
Pricop, Luminita
Wang, Zailong
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[38] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL
McInnes, Iain B.
Mease, Philip
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
RHEUMATOLOGY, 2017, 56 : 76 - 76
[39] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
McInnes, Kin B.
Mease, Philip J.
Ritchlin, Christopher T.
Rahman, Proton
Gottlieb, Alice B.
Kirkham, Bruce
Kajekar, Radhika
Delicha, Evie Maria
Pricop, Luminita
Mpofu, Shephard
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[40] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE PSORIATIC ARTHRITIS: 104 WEEKS RESULTS FROM A PHASE 3 TRIAL, FUTURE 2
McInnes, I. B.
Mease, P. J.
Ritchlin, C.
Rahman, P.
Gottlieb, A.
Kirkham, B.
Kajekar, R.
Delicha, E. M.
Pricop, L.
Mpofu, S.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 145 - 145

← 1 2 3 4 5 →